Evolent Health (EVH) Misses Q2 EPS by 3c; Offers Q3 & FY19 Revenues Guidance

August 6, 2019 4:47 PM

Evolent Health (NYSE: EVH) reported Q2 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found